Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Tella SH, Foster N, Qian S, Nguyen T, Borad MJ, McWilliams RR, Alberts SR, Wee Ma W, Chakrabarti S, Fruth B, Wessling J, Hartgers M, Washburn L, Fernandez-Zapico ME, Hogenson TL, Pitot H, Jin Z, Mahipal A.
Tella SH, et al. Among authors: wessling j.
Oncologist. 2023 Oct 3;28(10):917-e966. doi: 10.1093/oncolo/oyad144.
Oncologist. 2023.
PMID: 37339254
Free PMC article.
Clinical Trial.